RT Journal Article
SR Electronic
T1 The First Month of COVID-19 in Madagascar
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.23.20076463
DO 10.1101/2020.04.23.20076463
A1 Narison, Stephan
YR 2020
UL http://medrxiv.org/content/early/2020/05/14/2020.04.23.20076463.abstract
AB Using the officially published data and aware of the unclear source and insufficient number of samples, we present a first and (for the moment) unique attempt to study the spread of the pandemic COVID-19 in Madagascar. The approach has been tested by predicting the number of contaminated persons until 20 days after fitting the inputs data collected within 15 days using standard least, χ2-fit method. Encouraged by this first test, we add the new data collected within 30 days and give prevision until 33 days. We complete the analysis by using the updated data until 46 days. The data below 30 days show an approximate linear or quadratic polynomial increase of about (4-5) infected persons per day. A comparison with some other SI-like models is done. However, newer additional data collected until 46 days favours a cubic polynomial behaviour which signals an eventual near future stronger growth as confirmed by the data on the 48th day received after our study and our estimate including this new data for the next days. The analysis of the numbers of cured persons for 38 and 46 days shows behaviours similar to the ones of the infected persons. They indicate about 3 cured persons per day. These results for infected and cured persons may also be interpreted as the lowest values of the real cases due to the insufficient number of samples (about 3968 for 27 million inhabitants on 07/05/2020). Some social, economical and political impacts of COVID-19 and confinement for Madagascar and Worldwide are shortly discussed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research has not received any dedicated funds and sponsoring. It is issued from a personal initiative without any influence from private and public organizations.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used to get the results are in Table 3 of the paper where references to the sources can be found.